Immunohistochemical Evaluation of Ki-67 Expression in Erosive andNon-Erosive Oral Lichen Planus
نویسندگان
چکیده
منابع مشابه
immunohistochemical evaluation of ki-67 expression in erosive and non-erosive oral lichen planus
conclusions since ki-67 is extensively accepted as an important biomarker in diagnosis, prognosis and treatment of cancerous and precancerous lesions, a high degree of presence of this biomarker in chronic precancerous lesions, such as erosive olp, can be of great use in prognosis and suggested treatments. objectives this study aimed to evaluate ki-67 expression in erosive and non-erosive oral ...
متن کاملImmunohistochemical analysis of Ki-67 expression in oral lichen planus lesions
Introdouction: Lichen planus is a chronic, relatively common, dermal mucosa disease. The World Health Organization (WHO) has introduced lichen planus as a premalignant condition. Ki-67 is a protein that can be detected in all active phases of the cell cycle, especially in the G2 and M phases. Considering the major role of Ki-67 in the regulation of the cell cycle and the fact that it is one of ...
متن کاملErosive Palmoplantar Lichen Planus
Erosive palmoplantar lichen planus (LP), also known as ulcerative or bullous LP, was first described by Cram et al. in 1966 as a rare variant of LP that can affect mucous membranes, palms, and soles. It presents clinically as erythematous, ulcerated plaques that run an extremely chronic course and are resistant to all types of treatment. The patient was an 84-year-old woman with a personal hist...
متن کامل[Erosive palmoplantar lichen planus].
Erosive palmoplantar lichen planus (LP), also known as ulcerative or bullous LP, was first described by Cram et al. in 1966 as a rare variant of LP that can affect mucous membranes, palms, and soles. It presents clinically as erythematous, ulcerated plaques that run an extremely chronic course and are resistant to all types of treatment. The patient was an 84-year-old woman with a personal hist...
متن کاملOral erosive lichen planus treated with efalizumab.
A 54-year-old white woman presented with a 3-month history of progressive painful lesions on her tongue and oral mucosa. Her primary care physician initially treated her with nystatin and hydrogen peroxide, followed a few weeks later by acyclovir (Zovirax) ointment and a rapid 5-day prednisone taper, without improvement in her symptoms. Two months after the oral lesions developed, violaceous pa...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Avicenna Journal of Dental Research
سال: 2016
ISSN: 2008-7659,2423-7582
DOI: 10.17795/ajdr-25372